News & Events
New drug tested for relapsing-remitting MS
Results show daclizumab to be effective in reducing relapse rate and new lesions in relapsing-remitting MS
ABEM works with Brazilian mental health initiative
Brazilian MS Association ABEM is taking part in a campaign to highlight the importance of mental health…
Multiple Sclerosis Ireland launches report on the hidden costs of MS
On 21st October, MS Ireland launched a report on the costs of multiple sclerosis to Irish society
Global Patient Solidarity Day & UN Day for people with Disabilities
There are two World Days coming up which will be of interest to the global MS community.
Cast your vote
Which of these MS research areas would you like to hear more about?
Interview with Mauricio Farez
We spoke to an Argentinian researcher studying the correlation between melatonin and MS
New target for understanding secondary progressive MS
Chemical in the brain involved in signaling may play a role in progressive MS
Fingolimod safety and efficacy confirmed
The results of a seven-year follow-up study confirm the safety and efficacy of fingolimod
Exclusive breastfeeding is safe following childbirth
A German study shows that exclusive breastfeeding does not increase the risk of relapse after childbirth
MSIF and ECTRIMS hold first joint alumni event
Current and past fellows of MSIF and ECTRIMS come together in Barcelona to share experiences
Can Melatonin improve MS?
Study suggests that melatonin could be a possible cause of seasonal changes in MS disease activity
MSIF is seeking a Research Insight Analyst
We are seeking a Research Insight Analyst for a project this November